CSL report earnings this morning and the market expects a 9% increase in sales and EDITDA
Pepperstone
CSL report earnings this morning and the market expects a 9% increase in sales and EDITDA. NPAT profit is expected to come out at $683 million, while the pharma giant is likely to detail a dividend of 55c. It's not cheap on 22x forward PE, however it hasn't been cheap for some time and traders have been happy to pay up for the growth. A good result, backed by guidance that is unchanged from its October update of 10% constant currency NPAT growth could see the stock look to test the recent high of A$71.20.
Highly accomplished financial markets professional, with experience at a number of top-tier global institutions on both the buy and sell-side. A natural communicator with a strong ability to analyse macro-economic trends, capital flows and market...
Expertise
Highly accomplished financial markets professional, with experience at a number of top-tier global institutions on both the buy and sell-side. A natural communicator with a strong ability to analyse macro-economic trends, capital flows and market...